The work, they said, began decades ago with federal funding for basic research on bacterial immune systems. That led eventually, with more federal support, to the discovery of CRISPR. Federal investment in sequencing the human genome made it possible to identify KJ’s mutation. U.S. funding supported Dr. Liu’s lab and its editing discovery. A federal program to study gene editing supported Dr. Musunuru’s research. Going along in parallel was federally funded work that led to an understanding of KJ’s disease.

  • HubertManne@piefed.social
    link
    fedilink
    English
    arrow-up
    16
    arrow-down
    2
    ·
    21 hours ago

    This along with rna vaccines are one of the few technologies that give me hope for a bit of improvement. If it can become common.

    • JasonDJ@lemmy.zip
      link
      fedilink
      arrow-up
      3
      ·
      18 hours ago

      Correct me if I’m wrong, but I think RNA vaccines predate covid. At least conceptually. I think the covid vaccine was the first to scale it successfully.